Essay 01
Fragmentation is the operating cost of unaligned commercialization.
Excerpt
When commercial, medical, and access teams are measured against different definitions of success, the patient becomes the variable that absorbs the misalignment.
Every commercialization organization has a definition of success. The problem is that most have several, and they are rarely reconciled.
When commercial measures share of voice, medical measures scientific exchange, and access measures pull-through, the three functions optimize for different outcomes — and the patient becomes the variable that absorbs the misalignment in the form of delays, denials, and disengagement.
The remedy is not another dashboard. It is a single, executive-owned definition of what a successful patient journey looks like, instrumented end to end, and used as the shared scorecard across every function that touches it.
Bring this lens into a working session with your commercialization team.